glutamic acid has been researched along with rx 821002 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goiny, M; Herrera-Marschitz, M; Meana, JJ | 1 |
Assumpció Boronat, M; DeGregorio-Rocasolano, N; García-Sevilla, JA; Gasull, T; Lerma, J; Olmos, G; Paz Regalado, M; Trullas, R; Villarroel, A | 1 |
2 other study(ies) available for glutamic acid and rx 821002
Article | Year |
---|---|
In vivo modulation of norepinephrine and glutamate release through imidazoline receptors in the rat central nervous system.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Central Nervous System; Clonidine; Dioxanes; Glutamic Acid; Idazoxan; Imidazoline Receptors; Norepinephrine; Quinolines; Rats; Receptors, Drug | 1995 |
Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor.
Topics: Agmatine; Animals; Antazoline; Benzofurans; Cell Line; Cells, Cultured; Cerebellum; Dioxanes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Electrophysiology; Glutamic Acid; Humans; Idazoxan; Imidazoles; Neuroprotective Agents; Patch-Clamp Techniques; Potassium; Radioligand Assay; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Styrenes | 1999 |